Advancing clinical development through direct-to-patient models and Artificial Intelligence

  • Examining patient and site perceptions of direct-to-participant investigational product shipments
  • Understanding how decentralized distribution models influence engagement, site workload and data integrity
  • Exploring how AI is supporting trial design, operational efficiency and decision-making across the study lifecycle